A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

NCT03451526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2929

Last updated 2018-05-21

No results posted yet for this study

Summary

The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer

Conditions

Interventions

PROCEDURE

Surgeries

Surgeries plus adjuvant chemotherapies or perioperative chemotherapies

Sponsors & Collaborators

  • LinkDoc Technology (Beijing) Co. Ltd.

    collaborator INDUSTRY
  • Tang-Du Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2017-12-01
Completion
2018-03-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451526 on ClinicalTrials.gov